Cytomegalovirus Infection Is Associated with Increased Disease Activity and Worse Long-Term Course in Ulcerative Colitis. [PDF]
Vollenberg R +6 more
europepmc +1 more source
Intermittent Letermovir Dosing in Cytomegalovirus High-Risk Liver Transplant Recipients May Facilitate Development of Cell-Mediated Immunity and Prevent Post-Prophylaxis Infection. [PDF]
Kleiboeker HL, Saddler CM, Jorgenson MR.
europepmc +1 more source
Cytomegalovirus (CMV) Viremia Presenting as a Heart Failure Exacerbation. [PDF]
Lodha C, Basile EJ, Singireddy S.
europepmc +1 more source
Trichodysplasia Spinulosa in a Japanese Pediatric Patient. [PDF]
Tomita K +8 more
europepmc +1 more source
The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening. [PDF]
Harrison ER, Huskins WC, Schleiss MR.
europepmc +1 more source
Risk Factors for Breakthrough Cytomegalovirus Infections While on Prophylaxis in Kidney and Pancreas Transplant Recipients. [PDF]
Moody K +5 more
europepmc +1 more source
Response to the Letter by Sah and Kumbhalwar on "Population Pharmacokinetics and Dose Optimization of Valganciclovir and Ganciclovir in Lung Transplant Recipients". [PDF]
Dvořáčková E, Michaličková D.
europepmc +1 more source
Clinical-Stage Nanatinostat Triggers Productive Epstein-Barr Virus Lytic Replication. [PDF]
Akinyemi IA +6 more
europepmc +1 more source
Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients. [PDF]
Limaye AP +8 more
europepmc +1 more source
Subcutaneous Alemtuzumab as Salvage Therapy for Acute Kidney Transplant Rejection Following Thymoglobulin Anaphylaxis: A Pediatric Case Report. [PDF]
O'Connor KW +4 more
europepmc +1 more source

